IGF2BP2 is a member of the insulin-like growth factor pathway and it has been shown that its expression correlates with tumor progression in head and neck squamous cell carcinoma patients [48]. This evidence concerns the gene IGF2BP2 and head and neck squamous cell carcinoma.